Aphasia affects the ability to process language, including formulation and comprehension of language and speech, as well as the ability to read or write. Here is the latest research on aphasia.

September 16, 2021

Communication partner engagement: A relevant factor for functional outcomes in speech language therapy for aphasic dementia.

The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences
Emily RogalskiAlfred Rademaker
September 16, 2021
Open Access

Metabolic and Structural Signatures of Speech and Language Impairment in Corticobasal Syndrome: A Multimodal PET/MRI Study.

Frontiers in Neurology
Jacy Bezerra ParmeraArtur Martins Coutinho
September 15, 2021
Open Access

Structural Disconnection of the Posterior Medial Frontal Cortex Reduces Speech Error Monitoring

BioRxiv : the Preprint Server for Biology
J. McCallP. Turkeltaub
September 16, 2021

Suggestions for Improving the Investigation of Gesture in Aphasia.

Journal of Speech, Language, and Hearing Research : JSLHR
Brielle C StarkMelissa Duff
September 16, 2021

Two types of phonological reading impairment in stroke aphasia.

Brain Communications
Jonathan Vivian DickensP. Turkeltaub
September 14, 2021

Rates of longitudinal change in 18 F-flortaucipir PET vary by brain region, cognitive impairment, and age in atypical Alzheimer's disease.

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Jeffrey S PhillipsAlzheimer's Disease Neuroimaging Initiative
September 14, 2021

Multiple hippocampal transections for mesial temporal lobe epilepsy.

Surgical Neurology International
David PitskhelauriArmen Melikyan
September 14, 2021

Isolated thalamic stroke - analysis of clinical characteristics and asymmetry of lesion distribution in a retrospective cohort study.

Neurological Research and Practice
Martin A Schaller-PauleMaximilian Rauch
September 13, 2021

The Screening Test for Aphasia and Dysarthria (STAD) for patients with neurological communicative disorders: a large-scale, multicenter validation study in Japan.

Folia Phoniatrica Et Logopaedica : Official Organ of the International Association of Logopedics and Phoniatrics (IALP)
Kentaro ArakiEiji Shimizu
September 13, 2021

Assessment of aphasia: dialectical and cultural considerations in neurology.

J Peña-CasanovaA Soler-Campillo
September 11, 2021

Epilepsy-causing Reelin mutations result in impaired secretion and intracellular degradation of mutant proteins.

Human Molecular Genetics
Emanuela Dazzo, Carlo Nobile
September 11, 2021

Intracortical surface-based MR diffusivity to investigate neurologic and psychiatric disorders: a review.

Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging
Frederic Sampedro, Jaime Kulisevsky
September 11, 2021

Variability in sentence comprehension in aphasia in German.

Brain and Language
Dorothea PreglaNicole Stadie
September 10, 2021
Open Access

Current Update on the Clinical Utility of MMSE and MoCA for Stroke Patients in Asia: A Systematic Review.

International Journal of Environmental Research and Public Health
Julia KhawShazli Ezzat Ghazali
September 10, 2021
Open Access

Novel Advances to Post-Stroke Aphasia Pharmacology and Rehabilitation.

Journal of Clinical Medicine
Natalia CichonElzbieta Miller

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved